Filtricine Presents Research at Scientific Conference for Cancer Treatment

Dr. Grace Xiaolu Yang
November 1, 2019

At the AACR-NCI-EORTC conference for molecular targets (#Targets19) at Boston, we presented our latest preclinical research on treating colon cancer and boosting anti-PD-1 immunotherapy with our “targeted nutrient deprivation” technology.

We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2022 Filtricine, Inc. All Rights Reserved | by Wuilt